Clinical Trial: NCT04473911
Haplo Peripheral Blood Sct In GVHD Prevention
Status:
COMPLETEDPhase:
Phase 1| Lead Sponsor: | Zachariah Michael DeFilipp |
| Information Provided By: | Massachusetts General Hospital |
| Last Update Posted: | 2025-07-20 |
Study Overview
Brief Summary
This research study is studying the RGI-2001 for preventing Graft-vs-Host Disease (GVHD) in people with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), myeloproliferative disorders (MPN), chronic myelomonocytic leukemic (CMML), chemosensitive hodgkin lymphoma (HL), or Non-Hodgkin lymphoma (NHL).who will have a blood stem cell transplantation.
- GVHD is a condition in which cells from the donor's tissue attack the organs.
- RGI-2001 is an investigational treatment
Official Title
Conditions
Intervention / Treatment
- Drug: FLUDARABINE
- Drug: CYCLOPHOSPHAMIDE
- Radiation: TBI
- Drug: Melphalan
- Drug: Sirolimus
- Drug: Mycophenolate mofetil
- Drug: RGI-2001
- Drug: CYCLOPHOSPHAMIDE
Other Study ID Numbers
- 19-336
Start Date (Actual)
Primary Completion Date (Actual)
Study Completion Date (Actual)
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | Zachariah Michael DeFilipp |
| Information Provided By: | Massachusetts General Hospital |
| Last Update Posted: | 2025-07-20 |
Study Overview
Brief Summary
This research study is studying the RGI-2001 for preventing Graft-vs-Host Disease (GVHD) in people with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), myeloproliferative disorders (MPN), chronic myelomonocytic leukemic (CMML), chemosensitive hodgkin lymphoma (HL), or Non-Hodgkin lymphoma (NHL).who will have a blood stem cell transplantation.
- GVHD is a condition in which cells from the donor's tissue attack the organs.
- RGI-2001 is an investigational treatment
Official Title
Conditions
Intervention / Treatment
- Drug: FLUDARABINE
- Drug: CYCLOPHOSPHAMIDE
- Radiation: TBI
- Drug: Melphalan
- Drug: Sirolimus
- Drug: Mycophenolate mofetil
- Drug: RGI-2001
- Drug: CYCLOPHOSPHAMIDE
Other Study ID Numbers
- 19-336